期刊文献+

MMP-9和MMP-2在多病程大鼠EAE发病过程中的变化 被引量:1

The changes of expression of MMP-2 and MMP-9 in different course of EAE
下载PDF
导出
摘要 目的:研究MMP-2和MMP-9在多病程EAE不同类型间的变化,探讨MMPs在MS发病过程中的作用机制。方法:建立多病程大鼠EAE模型,以免疫组化的方法检测MMP-2、MMP-9在不同类型EAE中的表达及分布。结果:MMP-2、-9在EAE中的表达是一致的,不同类型EAE表达MMP-2、-9是不同的。1急性型EAE:炎细胞、血管内皮细胞及细胞外基质、脑膜细胞均呈阳性表达。2缓解-复发型EAE:活动性病灶呈阳性表达,非活动性病灶呈阴性表达。3持续进展型EAE:与缓解复发型EAE表达类似,但呈阳性表达的血管内皮细胞数目多于缓解-复发型。4良性型EAE:只有部分胶质细胞呈阳性表达。5隐匿型EAE-多数病灶呈轻度表达。结论:1 MMP-2、MMP-9在EAE中均有表达。2不同类型EAE中MMP-2、MMP-9的表达是不同的,与病理改变和疾病进展是一致和同步的。 Objective: To research the changes of MMP-2 and MMP-9 in different types of multi-course EAE and explore the pathogenesis of MMPs in EAE. Method: Establishing the EAE model and detecting the expression and distribution of MMP-2 and -9 in different type EAE with the method of IHC. Result: The expression of MMP-2 and -9 in EAE were concordant, but different type had different expression. (1) Acute EAE: MMP-2, -9 were expressed in vascular en-dothelial cells, meninges and inflammatory cells. (2) Relapsing-remitting EAE: part vascular endothelial cells, meningo-cytes and perivascular inflammatory' cells expressed MMP-2 and -9, more expression can be seen in ECM (3) Progressive EAE: similar to relapsing-remitting EAE, but there were more expression in vascular endothelial cells. (4) Benign form: MMP-2, -9 were expressed only in gliocytes. (5) Asymptomatic EAE: the expression of MMP-2, -9 can be seen in different levels. Conclusion: (1) the expression of MMP-2 and -9 were concordant in EAE. (2) Different type had different expression of MMP-2, -9 and the expressions were in coincident with the pathological change and progression of disease.
出处 《脑与神经疾病杂志》 2005年第3期169-171,共3页 Journal of Brain and Nervous Diseases
关键词 多发性硬化 实验性变态反应性脑脊髓炎 基质金属蛋白酶 作用机制 multiple sclerosis experimental allergic encephalomyelitis matrix metalloproteinases pathogenesis
  • 相关文献

参考文献9

  • 1董梅,刘瑞春,郭力,李春岩.Wistar大鼠实验性变态反应性脑脊髓炎的模型建立[J].脑与神经疾病杂志,2004,12(6):425-428. 被引量:19
  • 2吴二喜,王凤飞,NormanMcKIE.基质金属蛋白酶(英文)[J].生命科学研究,1999,3(3):175-194. 被引量:25
  • 3Cuzner ML,Davison AN,Rudge P.Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis.Ann Neurol. 1978,4:337-344.
  • 4Rosenberg GA, Dencoff JE, McGuire PG,et al. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab Invest 1994;71:417-422.
  • 5Gijbels K,proost P,Masure S,et al.Gelatinase B is present in the cerebrospinal fluid during experimental autolmmune encephalomyelitis and cleaves myelin basic protein. J Neurosci Res. 1993;36:432-440.
  • 6Maeda A,Sobel R. Matrix metalloproteinases in the normal human central nervous system, microglial nodules and multiple sclerosis. J Neuropathol Exp Neurol. 1996;55:300-309.
  • 7Kieseier BC,Seifert T, Giovannoni G, et al,matrix metalloproteinase in inflammatory demyelination. Neurology. 1999,53 (1):20-25.
  • 8Cuzer ML,Gveric D,Strand C,et al.The expression of tissue-type plasmirogen activator matrixmetalloproteinase and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J Neuro pathol Exp Neuroi. 1996;55:1194-1204.
  • 9Maeda A,Sobel RA.MatrixmetaHoproteinase in the normal human central nervous system,microglial nodules,and multiple sclerosislesion.J Neuro Phathol Exp Neurol.1996,55:300-309.

二级参考文献13

  • 1Nikki CO, Brien C, Brett C et al. Inhibition of nitric oxide synthase initiates relapsing remitting experimental autoimmune encephalomyelitis in rats, yet nitric oxide appears to be essential for clinical expression of disease. J Immunol, 2001,167(10):590
  • 2Legge KL, Min B, Bell JJ, et al. Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J Exp Med. 2000;191(12):2039
  • 3Giok K, Kuniko K, Naoyuki T, et al. Persistent expression of experimental autoimmune encephalomyelitis (EAE)-specific Vβ8.2 TCR spectrarype in the central nervous system of rats with chronic relapsing EAE. J Immunol, 1998,161(12):6993
  • 4Maatta JA, Eralinna JP, Roytta M, et al. Physical state of the neuroantigen in adjuvant emulsions determines encephalitogenic status in the BALB/c mouse. J Immunol Method. 1996,190:133
  • 5Fulumitsu H, Talase YS, Watanabe R. Neuropathology of autoimmune encephalomyelitis modified by retroviral infection. Neurophathology, 2002,22(4):280
  • 6Bert A, Sandra A. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous system. Curr Opin Neurol. 2003;16(3):375
  • 7John R. MacDougall,Lynn M. Matrisian. Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis[J] 1995,Cancer and Metastasis Reviews(4):351~362
  • 8胡学强,陆正齐,饶从志,吴金浪,吴义芳.实验性变应性猴脑脊髓炎的超微结构改变[J].中华神经科杂志,1998,31(6):333-335. 被引量:9
  • 9张凤蕴,吕雪莹,于伟玲,王丽群,王琳,李殿俊.实验性变态反应性脑脊髓炎几种细胞因子的检测[J].中国神经免疫学和神经病学杂志,2000,7(1):45-48. 被引量:8
  • 10彭聿平,邱一华,程纯,戴丽,黄慧伟.不同种系动物诱导实验性变态反应性脑脊髓炎模型的研究[J].南通医学院学报,2000,20(1):22-23. 被引量:8

共引文献42

同被引文献16

  • 1辛晋敏,马存根,梁丽云.实验性自身免疫性脑脊髓炎大鼠血-脑脊液屏障功能及动态变化[J].中国神经免疫学和神经病学杂志,2004,11(5):264-267. 被引量:12
  • 2王海峰,黄鉴政,赵嘉林,何向蕾,夏朝霞,闻树群.基质金属蛋白酶-9在实验性自身免疫性脑脊髓炎大鼠的表达[J].中国神经免疫学和神经病学杂志,2005,12(5):254-257. 被引量:6
  • 3Harkness K A, Adamson P, Sussman J D, et al. Dexamethasone regulation of matrix metalloproteinase expression in CNS vascular endothelium. Brain,2000, 123 (4) :698
  • 4Kurzepa J, Bartosik - Psujek H, Suchozebrska - Jesionek D, et al. Role of matrix metalloproteinase in the pathogenesis of multiple sclerosis. Neurol Neurochir Pol, 2005, 39( 1 ) :63
  • 5Reginster J Y, Deroisy R, Rovati LC, et al. Long - term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebocontrolled clinical trial. Lancet 2001,357(9252) : 251
  • 6Felson D T, McAlindon T E. Glucosamine and chondroitin for osteoarthritis: to recommend or not to recommend. Arthritis Care Res, 2000, 13(4) : 179
  • 7Zhang GX, Yu S, Gran B, et al. Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response. J Immunol, 2005,175 ( 11 ) :7202
  • 8Cuzer ML, Gveric D, Strand C, et al. The expression of tissue - type plasmirogen activator matrixmetalloproteinase and endogenous inhibitors in the central nervous system in multiple sclerosis : comparison of stages in lesion evolution. J Neuro pathol Exp Neuroi,1996,55:1194
  • 9Romanic AM, White RF, Arleth A J, et al. Matrix metalloproteinase expression increase after cerebral focal ischemia in rats, inhibition of matrix metalloproteinase - 9 reduces infact size. Stroke, 1998,29 (5) : 1020
  • 10Mathilde K, Volkan O Z, Annelie T, et al. Monocytederived dendritic cells express and secrete matrix degrading metalloproteinases and their inhibitors andare imbalanced in multiple sclerosis. J Neuroimmunol, 2002,126( 1 -2) :161

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部